-
Signature
-
/s/ Stephen Feider
-
Issuer symbol
-
BBNX
-
Transactions as of
-
03 Oct 2025
-
Net transactions value
-
-$82,668
-
Form type
-
4
-
Filing time
-
07 Oct 2025, 16:15:05 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Feider Stephen |
Chief Financial Officer |
C/O BETA BIONICS, INC., 11 HUGHES, IRVINE |
/s/ Stephen Feider |
07 Oct 2025 |
0002048588 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BBNX |
Common Stock |
Options Exercise |
$25,408 |
+4,982 |
+11% |
$5.10 |
49,023 |
03 Oct 2025 |
Direct |
|
| transaction |
BBNX |
Common Stock |
Sale |
$82,368 |
-3,828 |
-7.8% |
$21.52 |
45,195 |
03 Oct 2025 |
Direct |
F1, F2 |
| transaction |
BBNX |
Common Stock |
Sale |
$25,709 |
-1,154 |
-2.6% |
$22.28 |
44,041 |
03 Oct 2025 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
BBNX |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-4,982 |
-6.7% |
$0.000000 |
69,695 |
03 Oct 2025 |
Common Stock |
4,982 |
$5.10 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: